Circulating Tumour Cells & Circulating Tumour DNA in Patients with Resectable Colorectal Liver Metastases – A Prospective Cohort Study (the MIRACLE)
Lissa Wullaert(Erasmus MC Cancer Institute), Cornelis Verhoef(Erasmus MC Cancer Institute), Kelly R. Voigt(Erasmus MC Cancer Institute), Mai N. Van(Erasmus MC), Vanja de Weerd(Erasmus MC), Yannick Meyer(Erasmus MC Cancer Institute), Eric J.T. Belt(Albert Schweitzer Ziekenhuis), Stefan Sleijfer(Erasmus MC Cancer Institute), Maarten Vermaas(Association of British Orchestras), Stavros Makrodimitris(Erasmus MC), Paul D. Gobardhan(Amphia Ziekenhuis), John W.M. Martens(Erasmus MC), Dirk J. Grünhagen(Erasmus MC), Maurice P.H.M. Jansen(Erasmus MC Cancer Institute), Jaco Kraan(Erasmus MC Cancer Institute), Henk M.W. Verheul(Erasmus MC Cancer Institute), Saskia M. Wilting(Amsterdam UMC Location Vrije Universiteit Amsterdam), Corine M. Beaufort(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795